(Q45836927)

16 December 2017

title

Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma (English)

1 reference

16 December 2017

0 references

An Zhao

1

1 reference

16 December 2017

Guorong Li

2

1 reference

16 December 2017

Michel Péoc'h

3

1 reference

16 December 2017

Christian Genin

4

1 reference

16 December 2017

Marc Gigante

5

1 reference

16 December 2017

publication date

9 October 2012

1 reference

16 December 2017

Experimental and Molecular Pathology

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 December 2017

volume

94

1 reference

16 December 2017

issue

1

1 reference

16 December 2017

page(s)

115-120

1 reference

16 December 2017

MicroRNAs: novel biomarkers for human cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Oncomirs - microRNAs with a role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Prognostic significance of morphologic parameters in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Microarray analysis of microRNA expression in renal clear cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

MicroRNA control of signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Identification of a microRNA panel for clear-cell kidney cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Circulating microRNAs as stable blood-based markers for cancer detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

The VHL-dependent regulation of microRNAs in renal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

MicroRNA profiling of human kidney cancer subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

Circulating microRNAs in plasma of patients with gastric cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.005

10.1016/J.YEXMP.2012.10.005

7 January 2021

Identifiers

DOI

1 reference

16 December 2017

PubMed ID

23064048

1 reference

16 December 2017